At its highest approved dose for weight loss (3 mg daily), liraglutide has been associated with an average weight loss of about 5 to 10% of starting body weight , which is more modest than whats typically seen with tirzepatide
Gastrointestinal symptoms predominated, including nausea (36.9%), fatigue (16.7%), vomiting (16.3%), constipation (15.3%) and diarrhoea (12.6%)
There is no regulatory requirement that the compound be what the label says, at the concentration stated, or manufactured under conditions that protect against contamination
They are not FDA-approved, so their safety and effectiveness are not verified before they are used.Now, compounded medications aren't generics, which must be manufactured with the same ingredients and by the same processes as brand-name pharmaceuticals
the hormone-free week causes a crash in hormones, potentially leading to tiredness according to o3